Optimising the future patient centricity of prefilled syringes

Marcelo Cruz, VP of business Development and Marketing at Tjoapack, explores the secondary innovations poised to revolutionise the patient centricity of PFSs over the next decade.

The global prefilled syringe (PFS) market was worth $7.91 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% to reach $20.62 billion by 2032. Europe dominated the global market in 2023 with a share of 40.33%. 

One of the key reasons behind the success of the PFS format is the improved patient experience it offers. Coming already charged with a single dose, the PFS…